AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
AMLODIPINE BESYLATE; VALSARTAN in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXFORGE TABLET, COATED; ORAL | 2013/12.3.47/4765 | NOVARTIS PHARMACEUTICAL CORPORATION | active | 31 Dec 2027 |
| EXFORGE TABLET, COATED; ORAL | 2013/12.3.5/4767 | NOVARTIS PHARMACEUTICAL CORPORATION | active | 31 Dec 2027 |
| VALPLUS 10+ TABLET, COATED; ORAL | 2024/12.3.5/6590 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| EXFORGE TABLET, COATED; ORAL | 2013/12.3.5/4766 | NOVARTIS PHARMACEUTICAL CORPORATION | active | 31 Dec 2027 |
AMLODIPINE BESYLATE; VALSARTAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing AMLODIPINE BESYLATE; VALSARTAN, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AMLODIPINE BESYLATE; VALSARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.